← SynDRA
EDELINONTRINE
SynDRA canonical compound SYN0034172 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PDE9A |
|---|
| Mechanism of action | Phosphodiesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
- PDE9A INHIBITOR
- Phosphodiesterase 9A inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PDE1A
- PDE1C
- PDE1B
- ABL1
- PDE8B
- PDE7B
- PDE5A
- PDE4C
- PDE3A
- MAPK1
- AURKA
- HDAC6
- GSK3B
- FGFR2
- CSNK1D
- CDK2
- BRPF1
- BRD4
- TRIM24
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Edelinontrina
- Crd-740
- Pf-04447943
- CRD740
- PF-4447943
- PF04447943
- PF4447943
- BCP16255
- PF-04447943
- 7N969W8Y4O
- RefChem:928926
- DTXCID001509859
- PF 4447943
- MFCD22665724
- CRD-740
- UNII-7N969W8Y4O
- C20H25N7O2
- edelinontrine [INN]
- CS-0942
- Edelinontrine [WHO-DD]
- Edelinontrine (USAN/INN)
- EDELINONTRINE [USAN]
- orb1706823
- SCHEMBL1716847
- SCHEMBL20588503
- IWXUVYOOUMLUTQ-CZUORRHYSA-N
- GLXC-10130
- EX-A7959
- HTB74420
- BDBM50397838
- AKOS030238886
- AKOS040742392
- EBC-501082
- NCGC00379008-02
- AS-35203
- DA-76755
- HY-15441
- NS00072900
- D13001
Look up EDELINONTRINE in the interactive SynDRA portal →